Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Botulinum toxin type A injections are not effective for severe alopecia areata.

Dermoscopy is a useful tool for diagnosing and managing alopecia areata.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Phototherapy can help treat hair loss in alopecia areata.

Skin organoids from stem cells can help study and treat skin issues but face some challenges.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Mycophenolic acid effectively improved hair and nail growth in a lupus patient.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Routine eye exams may be needed for alopecia areata patients due to common eye issues.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Alopecia areata affects many in the US, impacting quality of life, with limited treatment options.

Oral cyclosporine can help regrow hair in severe alopecia areata cases.

Quercetin effectively treated and prevented hair loss in mice.

Squaric acid dibutylester effectively treats alopecia areata.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Alopecia areata patients have lower vitamin D levels than healthy individuals.

Vitamin D receptor FokI gene variation is not linked to alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.